BioE Home

News Story

Josh Gammon Named PhRMA Foundation Doctoral Fellow

Josh Gammon Named PhRMA Foundation Doctoral Fellow


Fischell Department of Bioengineering graduate student Josh Gammon was named the recipient of the PhRMA Foundation Pharmaceutics Fellowship. The two-year doctoral fellowship will support Gammon’s research using modulatory signals to control immune function.

The Waldorf, Md. native is working in the Jewell Research Lab to apply biomaterials for the controlled delivery of immunomodulatory agents and antigens to develop more effective and safe treatments for autoimmune disease and cancer. 

“This fellowship will provide me with additional funding to conduct proposed experiments, and the opportunity to present my research and network with my peers at conferences in the future,” Gammon said. 

Gammon graduated with a B.S. bioengineering from the Fischell Department of Bioengineering in 2012. Prior to receiving the PhRMA Foundation fellowship, he also received a Pediatric Oncology Student Training award from Alex’s Lemonade Stand Foundation.

Related Articles:
Jewell Lab Research Featured as Transplantation Cover Story
Jewell Awarded $1.4 Million NIH Grant for Novel Multiple Sclerosis Research
BIOE Student Wins Prestigious Lemelson-MIT Student Prize
Jewell Named AIChE 2018 NSEF Young Investigator, Owens Corning Recipient
Clyne, Maisel to Join BIOE Faculty in 2019
Three BIOE Professors Awarded NIH R01s in as Many Months
Anjana Jeyaram Named PhRMA Foundation Predoctoral Fellow
BIOE Researchers Develop New Technologies to Drive Next-Generation Therapies for Multiple Sclerosis
BIOE Researcher Works to Advance MS, Autoimmune Disease Research
Jewell Named Science Translational Medicine Associate Scientific Advisor

June 5, 2017


Prev   Next